Danese S - Search Results

1

Anti-adhesion Molecules in IBD: Does Gut Selectivity Really Make the Difference?

D'Amico F, Roda G, Peyrin-Biroulet L, Danese S. D'Amico F, et al. Among authors: danese s. Curr Pharm Des. 2019;25(1):19-24. doi: 10.2174/1381612825666190307165703. Curr Pharm Des. 2019. PMID: 30848193 Review.

2

Biological therapies for inflammatory bowel disease: research drives clinics.

Danese S, Semeraro S, Armuzzi A, Papa A, Gasbarrini A. Danese S, et al. Mini Rev Med Chem. 2006 Jul;6(7):771-84. doi: 10.2174/138955706777698624. Mini Rev Med Chem. 2006. PMID: 16842127 Review.

3

Tumor necrosis factor-alpha monoclonal antibodies for Crohn's disease: tipping the balance.

Danese S, Pagano N, Angelucci E, Stefanelli T, Repici A, Omodei P, Daperno M, Malesci A. Danese S, et al. Curr Med Chem. 2007;14(14):1489-97. doi: 10.2174/092986707780831104. Curr Med Chem. 2007. PMID: 17584058 Review.

4

New insights into inflammatory bowel disease pathophysiology: paving the way for novel therapeutic targets.

Stefanelli T, Malesci A, Repici A, Vetrano S, Danese S. Stefanelli T, et al. Among authors: danese s. Curr Drug Targets. 2008 May;9(5):413-8. doi: 10.2174/138945008784221170. Curr Drug Targets. 2008. PMID: 18473770 Review.

5

Anti-adhesion molecule therapies in inflammatory bowel disease: touch and go.

Stefanelli T, Malesci A, De La Rue SA, Danese S. Stefanelli T, et al. Among authors: danese s. Autoimmun Rev. 2008 May;7(5):364-9. doi: 10.1016/j.autrev.2008.01.002. Epub 2008 Feb 12. Autoimmun Rev. 2008. PMID: 18486923 Review.

6

Early combined immunosuppression in Crohn's disease.

Danese S, Peyrin-Biroulet L. Danese S, et al. Lancet. 2008 Jun 14;371(9629):1996; author reply 1996-7. doi: 10.1016/S0140-6736(08)60862-4. Lancet. 2008. PMID: 18555908 No abstract available.

7

Step-up and top-down approaches to the treatment of Crohn's disease: early may already be too late.

Peyrin-Biroulet L, Bigard MA, Malesci A, Danese S. Peyrin-Biroulet L, et al. Among authors: danese s. Gastroenterology. 2008 Oct;135(4):1420-2. doi: 10.1053/j.gastro.2008.08.017. Epub 2008 Sep 4. Gastroenterology. 2008. PMID: 18773901 No abstract available.

8

The role of MAPK in governing lymphocyte adhesion to and migration across the microvasculature in inflammatory bowel disease.

Scaldaferri F, Sans M, Vetrano S, Correale C, Arena V, Pagano N, Rando G, Romeo F, Potenza AE, Repici A, Malesci A, Danese S. Scaldaferri F, et al. Among authors: danese s. Eur J Immunol. 2009 Jan;39(1):290-300. doi: 10.1002/eji.200838316. Eur J Immunol. 2009. PMID: 19130554 Free article.

9

New and emerging biologics in the treatment of inflammatory bowel disease: quo vadis?

Danese S, Angelucci E. Danese S, et al. Gastroenterol Clin Biol. 2009 Jun;33 Suppl 3:S217-27. doi: 10.1016/S0399-8320(09)73157-4. Gastroenterol Clin Biol. 2009. PMID: 20117345 Free article. Review.

10

Efficacy of TNF antagonists beyond one year in adult and pediatric inflammatory bowel diseases: a systematic review.

Oussalah A, Danese S, Peyrin-Biroulet L. Oussalah A, et al. Among authors: danese s. Curr Drug Targets. 2010 Feb;11(2):156-75. doi: 10.2174/138945010790309939. Curr Drug Targets. 2010. PMID: 20210765 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,210 results

Search Page

Filters